Trademark: 78755226
Status Date
Monday, June 14, 2010
Filing Date
Wednesday, November 16, 2005
Published for Opposition
Tuesday, July 25, 2006
Abandoned Date
Friday, June 11, 2010
5 Pharmaceutical products and preparations in the form of a suspension intravenously administered to the patients for the treatment of thalassemia and sickle cell anemia, for use in connection with bone marrow transplants
Jun 14, 2010
Abandonment Notice Mailed - After Publication
Jun 14, 2010
Abandonment - After Publication
Jun 11, 2010
Teas Express Abandonment Received
Jun 7, 2010
Teas Change Of Correspondence Received
Jun 7, 2010
Teas Change Of Correspondence Received
Dec 14, 2009
Extension 5 Granted
Dec 10, 2009
Extension 5 Filed
Dec 10, 2009
Teas Extension Received
Mar 12, 2009
Extension 4 Granted
Mar 10, 2009
Extension 4 Filed
Mar 10, 2009
Teas Extension Received
Dec 19, 2008
Extension 3 Granted
Dec 5, 2008
Extension 3 Filed
Dec 18, 2008
Case Assigned To Intent To Use Paralegal
Dec 5, 2008
Teas Extension Received
Jul 1, 2008
Teas Change Of Correspondence Received
Jun 16, 2008
Extension 2 Granted
Jun 10, 2008
Extension 2 Filed
Jun 10, 2008
Teas Extension Received
Jan 4, 2008
Extension 1 Granted
Dec 11, 2007
Extension 1 Filed
Dec 11, 2007
Teas Extension Received
Jun 20, 2007
Undeliverable Mail - Corresp. Remailed
Jun 12, 2007
Noa Mailed - Sou Required From Applicant
Feb 6, 2007
Extension Of Time To Oppose Process - Terminated
Dec 7, 2006
Changes/Corrections After Pub Approval Entered
Dec 7, 2006
Assigned To Petition Staff
Nov 21, 2006
Paper Received
Aug 16, 2006
Extension Of Time To Oppose Received
Jul 25, 2006
Published For Opposition
Jul 5, 2006
Notice Of Publication
Jun 6, 2006
Law Office Publication Review Completed
Jun 2, 2006
Assigned To Lie
May 30, 2006
Approved For Pub - Principal Register
May 22, 2006
Assigned To Examiner
Nov 22, 2005
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
